ArriVent Biopharma IPO

ArriVent Biopharma is a drug development platform that sources oncology therapies from around the world and drives them through the approval process.

Register for Details

For more details on financing and valuation for ArriVent Biopharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is ArriVent Biopharma's ticker symbol?

ArriVent Biopharma does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is ArriVent Biopharma's stock price?

The stock price for ArriVent Biopharma will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

ArriVent Biopharma Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
12/16/2022 Series B $375.08MM $XXX.XX $XXX.XX
6/30/2021 Series A $230.77MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about ArriVent Biopharma

What is ArriVent Biopharma funding to date?

ArriVent Biopharma has raised $260MM with the following series:
$230.77MM for Series A, $375.08MM for Series B

When was ArriVent Biopharma founded?

ArriVent Biopharma was founded in 2021.

Can you invest in ArriVent Biopharma?

ArriVent Biopharma is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell ArriVent Biopharma share pre-IPO?

If you own ArriVent Biopharma pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Is ArriVent Biopharma a publicly traded company?

ArriVent Biopharma is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like ArriVent Biopharma in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$327.39MM
Sector